Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Director | August 10, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date August 10, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $238.91 · Expires 2036-08-10 | Direct | 1,506 |
Reported balance
After 2026-08-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-10 · Grant · Acquired 1,506 · Balance 1,506 F1: These nonqualified stock options are fully vested and are exercisable immediately. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 3,408 |
Reported balance
After 2026-08-10 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-10 · Grant · Acquired 512 · Balance 3,408 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
Filing footnotes · ownership attribution and instrument terms
F1: These nonqualified stock options are fully vested and are exercisable immediately.
F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Avid Bioservices, Inc.
Report date February 05, 2025 · Filed February 07, 2025
Section 16 reporting ended · disclosed 2025-02-07. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-02-05 transaction · row 1
1 source rowRow 1 · 2025-02-05 · Disposition to issuer · Disposed 37,746 · Balance 0 F1: Represents shares of common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Space Mergerco, Inc. ("Merger Sub") with and into Avid Bioservices, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the "Merger Agreement"), by and among the Issuer, Space Finco, Inc., and Merger Sub. F2: At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $26.03 · Expires 2028-07-09 | Direct | 0 |
Reported balance
After 2025-02-05 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-02-05 · Disposition to issuer · Disposed 8,376 · Balance 0 F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2025-02-05 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-02-05 · Disposition to issuer · Disposed 8,147 · Balance 0 F5: Represents restricted stock units ("RSUs") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F6: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Space Mergerco, Inc. ("Merger Sub") with and into Avid Bioservices, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the "Merger Agreement"), by and among the Issuer, Space Finco, Inc., and Merger Sub.
F2: At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration").
F3: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub.
F4: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement.
F5: Represents restricted stock units ("RSUs") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub.
F6: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 10, 2026 Filed Aug 12, 2026 20:31 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 512 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-056257 · wk-form4_1786566666.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,408 Underlying: Ordinary Shares · 512 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 10, 2026 Filed Aug 12, 2026 20:31 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 1,506 | $0.00 Strike: $238.91 | $0.00 |
DisclosureSEC source: 0001628280-26-056257 · wk-form4_1786566666.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,506 Underlying: Ordinary Shares · 1,506 shares Expires 2036-08-10 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:21 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 487 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-039966 · wk-form4_1755033664.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 Underlying: Ordinary Shares · 487 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2025 Filed Aug 12, 2025 21:21 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 1,407 | $0.00 Strike: $242.85 | $0.00 |
DisclosureSEC source: 0001628280-25-039966 · wk-form4_1755033664.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,407 Underlying: Ordinary Shares · 1,407 shares Expires 2035-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 19:37 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Disposition to issuerRestricted Stock Units · Derivative | 8,147 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001683168-25-000854 · ownership.xml · derivative · entry 3 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,147 shares Expires not disclosed F5 · shares: Represents restricted stock units ("RSUs") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F6 · price: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement. F6 · derivative.exercise_date: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement. F6 · derivative.expiration_date: At the Effective Time, each unvested RSU was cancelled and converted solely into the right to receive a cash payment of $12.50 per share of common stock subject to such unvested RSU, without interest, subject to the terms and conditions of the Merger Agreement. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 19:37 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Disposition to issuerStock Option (right to buy) · Derivative | 8,376 | Not disclosed Strike: $26.03 | Not disclosed |
DisclosureSEC source: 0001683168-25-000854 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,376 shares Expires 2028-07-09 F3 · shares: Represents stock options ("Options") that were disposed of at the Effective Time of the Merger of Merger Sub with and into the Issuer pursuant to the Merger Agreement, by and among the Issuer, Space Finco, Inc., and Merger Sub. F4 · price: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. F4 · derivative.exercise_date: This Option was fully vested at the Effective Time. At the Effective Time, each fully vested Option was cancelled and converted solely into the right to receive a cash payment equal to the product of (a) the total number of shares of common stock subject to such Option immediately prior to the Effective Time, multiplied by (b) the excess, if any, of the Merger Consideration over the per share exercise price of such vested Option, without interest, subject to the terms and conditions of the Merger Agreement. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 19:37 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Disposition to issuerCommon Stock, $0.001 par value | 37,746 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-25-000854 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents shares of common stock that were disposed of at the effective time (the "Effective Time") of the merger (the "Merger") of Space Mergerco, Inc. ("Merger Sub") with and into Avid Bioservices, Inc. (the "Issuer") pursuant to the Agreement and Plan of Merger, dated as of November 6, 2024 (the "Merger Agreement"), by and among the Issuer, Space Finco, Inc., and Merger Sub. F2 · price: At the Effective Time, each outstanding share of common stock was cancelled and converted into the right to receive a cash payment per share of $12.50, without interest, subject to the terms and conditions of the Merger Agreement (the "Merger Consideration"). Read SEC document |
| December 14, 2024 Filed Dec 17, 2024 19:46 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantRestricted Stock Units · Derivative | 8,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-24-008800 · ownership.xml · derivative · entry 3 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,147 Underlying: Common Stock · 8,147 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F3 · kind: Annual equity award grant pursuant to the Issuer's non-employee director compensation program. F4 · derivative.exercise_date: RSUs granted to the reporting person on December 14, 2024 shall fully vest on December 14, 2025, subject to the reporting person's continuous service to the Issuer on such vesting date. F4 · derivative.expiration_date: RSUs granted to the reporting person on December 14, 2024 shall fully vest on December 14, 2025, subject to the reporting person's continuous service to the Issuer on such vesting date. Read SEC document |
| December 14, 2024 Filed Dec 17, 2024 19:46 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionRestricted Stock Units · Derivative | 26,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-24-008800 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,756 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · derivative.exercise_date: RSUs granted to the reporting person on December 14, 2023 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2024. F2 · derivative.expiration_date: RSUs granted to the reporting person on December 14, 2023 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2024. Read SEC document |
| December 14, 2024 Filed Dec 17, 2024 19:46 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionCommon Stock, $0.001 par value | 26,756 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-24-008800 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,746 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:31 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036783 · wk-form4_1723494663.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,409 Underlying: Ordinary Shares · 988 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| July 09, 2024 Filed Jul 11, 2024 17:00 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionRestricted Stock Units · Derivative | 689 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-24-004760 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,756 Underlying: Common Stock · 689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units granted to the reporting person on July 9, 2021, vested in three (3) equal annual installments beginning July 9, 2022 and each year thereafter until July 9, 2024. F2 · derivative.expiration_date: The Restricted Stock Units granted to the reporting person on July 9, 2021, vested in three (3) equal annual installments beginning July 9, 2022 and each year thereafter until July 9, 2024. Read SEC document |
| July 09, 2024 Filed Jul 11, 2024 17:00 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionCommon Stock, $0.001 par value | 689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-24-004760 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 19:29 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantRestricted Stock Units · Derivative | 26,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-008936 · ownership.xml · derivative · entry 3 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,445 Underlying: Common Stock · 26,756 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F3 · kind: Annual equity award grant pursuant to the Issuer's non-employee director compensation program. F4 · derivative.exercise_date: RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date. F4 · derivative.expiration_date: RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 19:29 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionRestricted Stock Units · Derivative | 9,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-008936 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 689 Underlying: Common Stock · 9,612 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · derivative.exercise_date: RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023. F2 · derivative.expiration_date: RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 19:29 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionCommon Stock, $0.001 par value | 9,612 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-23-008936 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,301 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Read SEC document |
| August 03, 2023 Filed Aug 7, 2023 20:35 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 1,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-044827 · doc4.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,421 Underlying: Ordinary Shares · 1,050 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| July 09, 2023 Filed Jul 11, 2023 20:11 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionRestricted Stock Units · Derivative | 689 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-23-004787 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,301 Underlying: Common Stock · 689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units granted to the reporting person on July 9, 2021, vest in three (3) equal annual installments beginning July 9, 2022 and each year thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. F2 · derivative.expiration_date: The Restricted Stock Units granted to the reporting person on July 9, 2021, vest in three (3) equal annual installments beginning July 9, 2022 and each year thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. Read SEC document |
| July 09, 2023 Filed Jul 11, 2023 20:11 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionCommon Stock, $0.001 par value | 689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-23-004787 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 20:31 UTC | STERIS plc STE · Entity 3228 | GrantCareer Restricted Stock Units · Derivative | 371 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-033768 · doc4.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371 Underlying: Ordinary Shares · 371 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| January 13, 2023 Filed Jan 17, 2023 19:41 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | SaleCommon Stock, $0.001 par value | 5,321 | $16.32 | $86,856.28 |
DisclosureSEC source: 0001683168-23-000207 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Represents a weighted average sales price per share. These shares were sold at prices ranging from $16.32 to $16.345. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares sold at each respective price within the range set forth in this footnote. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 19:59 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantRestricted Stock Units · Derivative | 9,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-22-008494 · ownership.xml · derivative · entry 3 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,990 Underlying: Common Stock · 9,612 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F3 · kind: Annual equity award grant pursuant to the Issuer's non-employee director compensation program. F4 · derivative.exercise_date: The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date. F4 · derivative.expiration_date: The RSUs granted to the reported person on December 14, 2022 shall fully vest on December 14, 2023, subject to the reporting person's continuous service to the Issuer on such vesting date. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 19:59 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionRestricted Stock Units · Derivative | 4,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-22-008494 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,378 Underlying: Common Stock · 4,632 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · derivative.exercise_date: RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022. F2 · derivative.expiration_date: RSUs granted to the reporting person on December 14, 2021 pursuant to the Issuer's non-employee director compensation program which fully vested on December 14, 2022. Read SEC document |
| December 14, 2022 Filed Dec 16, 2022 19:59 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionCommon Stock, $0.001 par value | 4,632 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-22-008494 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,321 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Read SEC document |
| July 09, 2022 Filed Jul 12, 2022 20:33 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionRestricted Stock Units · Derivative | 689 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-22-004916 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,010 Underlying: Common Stock · 689 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · derivative.exercise_date: RSUs granted to the reporting person on July 9, 2021 vest one-third on July 9, 2022 and on each one-year anniversary thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. F2 · derivative.expiration_date: RSUs granted to the reporting person on July 9, 2021 vest one-third on July 9, 2022 and on each one-year anniversary thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. Read SEC document |
| July 09, 2022 Filed Jul 12, 2022 20:33 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | Exercise / conversionCommon Stock, $0.001 par value | 689 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001683168-22-004916 · ownership.xml · nonDerivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 21:30 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantRestricted Stock Units · Derivative | 4,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-21-006432 · ownership.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,699 Underlying: Common Stock · 4,632 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock. F2 · kind: Annual equity award grant pursuant to the Issuer's non-employee director compensation program. F3 · derivative.exercise_date: The RSUs granted to the reporting person shall fully vest on December 14, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date. F3 · derivative.expiration_date: The RSUs granted to the reporting person shall fully vest on December 14, 2022, subject to the reporting person's continuous service to the Issuer on such vesting date. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:35 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantRestricted Stock Units · Derivative | 2,067 | $0.00 | $0.00 |
DisclosureSEC source: 0001683168-21-002944 · ownership.xml · derivative · entry 2 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,067 Underlying: Common Stock · 2,067 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's Common Stock. F3 · derivative.exercise_date: One-third of the RSUs granted to the reporting person shall vest on July 9, 2022 and on each one-year anniversary thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. F3 · derivative.expiration_date: One-third of the RSUs granted to the reporting person shall vest on July 9, 2022 and on each one-year anniversary thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. Read SEC document |
| July 09, 2021 Filed Jul 13, 2021 21:35 UTC | Avid Bioservices, Inc. CDMO · Entity 83494 | GrantStock Option (right to buy) · Derivative | 8,376 | $0.00 Strike: $26.03 | $0.00 |
DisclosureSEC source: 0001683168-21-002944 · ownership.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,376 Underlying: Common Stock · 8,376 shares Expires 2028-07-09 F1 · derivative.exercise_date: One-third of the stock options granted to the reporting person shall vest on July 9, 2022 and on each one-year anniversary thereafter until fully vested, subject to the reporting person's continuous service to the Issuer on such vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.